Ensign Peak Advisors’s PetMed Express PETS Stock Holding History

Ensign Peak Advisors’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25,627	Closed	-$263K	–	1757
2023 Q3	$263K	Hold	25,627	–	–	﹤0.01%	1707
2023 Q2	$353K	Buy	25,627 +3,900	+18%	+$58.5K	﹤0.01%	1696
2023 Q1	$353K	Buy	21,727 +550	+3%	+$10.4K	﹤0.01%	1696
2022 Q4	$375K	Buy	21,177 +7,450	+54%	+$148K	﹤0.01%	1687
2022 Q3	$268K	Hold	13,727	–	–	﹤0.01%	1757
2022 Q2	$273K	Hold	13,727	–	–	﹤0.01%	1707
2022 Q1	$354K	Hold	13,727	–	–	﹤0.01%	1694
2021 Q4	$347K	Sell	13,727 -11,490	-46%	-$318K	﹤0.01%	1763
2021 Q3	$678K	Hold	25,217	–	–	﹤0.01%	1555
2021 Q2	$803K	Hold	25,217	–	–	﹤0.01%	1493
2021 Q1	$887K	Hold	25,217	–	–	﹤0.01%	1462
2020 Q4	$808K	Hold	25,217	–	–	﹤0.01%	1482
2020 Q3	$797K	Hold	25,217	–	–	﹤0.01%	1407
2020 Q2	$899K	Hold	25,217	–	–	﹤0.01%	1312
2020 Q1	$726K	Hold	25,217	–	–	﹤0.01%	1279
2019 Q4	$593K	Buy	+25,217	New	+$565K	﹤0.01%	1486

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ensign Peak Advisors's PETS Position: Q4 2023 in Review

Ensign Peak Advisors sold out of PetMed Express (PETS) in Q4 2023, closing a stake of 25,627 shares — an estimated $263K sold.

Ensign Peak Advisors first reported a position in PETS in Q4 2019 and held it in 16 quarters. The position peaked at $899K in Q2 2020. 130 funds tracked by Wall St. Rank hold PETS as of Q4 2023.

Ensign Peak Advisors reported no remaining PetMed Express position as of Q4 2023 after selling out during the quarter.
Ensign Peak Advisors sold 25,627 PetMed Express shares in Q4 2023, an estimated $263K.
Ensign Peak Advisors first reported a position in PetMed Express in Q4 2019 and held it in 16 quarters.
Ensign Peak Advisors's PetMed Express position peaked at $899K in Q2 2020.
130 funds tracked by Wall St. Rank held PetMed Express as of Q4 2023.

Based on Ensign Peak Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.